Comparison of appetite responses to high- and low-glycemic index postexercise meals under matched insulinemia and fiber in type 1 diabetes

The American Journal of Clinical Nutrition
Matthew D CampbellDaniel J West

Abstract

Patients with type 1 diabetes face heightened risk of hypoglycemia after exercise. Subsequent overfeeding, as a preventative measure against hypoglycemia, negates the energy deficit after exercise. Patients are also required to reduce the insulin dose administered with postexercise foods to further combat hypoglycemia. However, the insulin dose is dictated solely by the carbohydrate content, even though postprandial glycemia is vastly influenced by glycemic index (GI). With a need to control the postexercise energy balance, appetite responses after meals differing in GI are of particular interest. We assessed the appetite response to low-glycemic index (LGI) and high-glycemic index (HGI) postexercise meals in type 1 diabetes patients. This assessment also offered us the opportunity to evaluate the influence of GI on appetite responses independently of insulinemia, which confounds findings in individuals without diabetes. Ten physically active men with type 1 diabetes completed 2 trials in a randomized crossover design. After 45 min of treadmill exercise at 70% of the peak oxygen uptake, participants consumed an LGI (GI ∼37) or HGI (GI ∼92) meal with a matched macronutrient composition, negligible fiber content, and standardized...Continue Reading

Associated Clinical Trials

References

Dec 1, 1989·Appetite·C P Sepple, N W Read
Jan 1, 1986·The American Journal of Clinical Nutrition·T M Wolever, D J Jenkins
Aug 1, 1974·Journal of Applied Physiology·D B Dill, D L Costill
Jun 1, 1984·Experimental and Molecular Pathology·E K ChanH Buchwald
Oct 19, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·A W RussellI M Chapman
Mar 20, 2002·Pharmacology, Biochemistry, and Behavior·Ellen L AirStephen C Woods
Dec 13, 2006·The American Journal of Clinical Nutrition·Anne FlintArne Astrup
Jun 1, 2005·Nutrition Research Reviews·F BrounsT M S Wolever
Mar 21, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity·Alistair N Lumb, Ian W Gallen
Sep 17, 2009·Pediatric Diabetes·Kenneth RobertsonMichael C Riddell
Jun 15, 2010·Medicine and Science in Sports and Exercise·Daniel J WestRichard M Bracken
Nov 26, 2010·The New England Journal of Medicine·Thomas Meinert LarsenUNKNOWN Diet, Obesity, and Genes (Diogenes) Project
Jan 5, 2011·Diabetes, Obesity & Metabolism·I W GallenA Lumb
Jun 16, 2011·The Physician and Sportsmedicine·Lisa ChuMichael C Riddell
Aug 3, 2012·Journal of the American College of Nutrition·Javier T Gonzalez, Emma J Stevenson
Mar 21, 2013·Journal of Science and Medicine in Sport·Marie-Christine DubéS John Weisnagel

❮ Previous
Next ❯

Citations

Oct 24, 2017·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shi-Ying ShaoXue-Feng Yu
Dec 15, 2019·Nutrients·Sam ScottChristoph Stettler
Jul 6, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Emma HowardMatthew D Campbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.